FDA Approves Egalet Morphine Pill with Narrow Abuse-Deterrent Label

The FDA approved Egalet’s extended-release morphine tablet, Arymo ER, for daily, around-the-clock pain treatment, with labeling describing physical properties that can deter abuse through injection. However, abuse by nasal and oral routes is still possible, the agency said.
Source: Clinical Trials Advisor